Former Galena chief Mark Ahn back in hot water as DOJ levels insider trading charges for consultant work

When Mark Ahn departed troubled Galena Pharmaceuticals back in 2014, he told investors he looking to pursue other “long-held” goals. Turns out one of those goals may allegedly have been peddling stock based on insider info.